XML 27 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1

8. Generic Drugs License

3 Months Ended

Mar. 31, 2017

Generic Drugs License

8. Generic Drugs License

In 2016, the Company entered into License Agreements for the following four Generic Drugs:

●	Anastrozole (brand name Arimidex® by AstraZenica) for treatment of Breast Cancer
●	Letrozole (brand name Femara® by Novartis) for treatment of Breast Cancer

●	Bicalutamide (brand name Casodex® by AstraZenica) for treatment of Prostate Cancer
●	Finasteride (brand name Propecia® by Merck) for treatment of Benign Prostatic Hyperplasia

The cost of these Licenses has been fully expensed.

X

- References

No definition available.

+ Details

Name:	SBFM_GenericDrugsLicenseAbstract
Namespace Prefix:	SBFM_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	SBFM_GenericDrugsLicenseDisclosureTextBlock
Namespace Prefix:	SBFM_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration